341 related articles for article (PubMed ID: 25691093)
1. Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes.
de Sousa RT; Zanetti MV; Talib LL; Serpa MH; Chaim TM; Carvalho AF; Brunoni AR; Busatto GF; Gattaz WF; Machado-Vieira R
J Psychiatr Res; 2015 Mar; 62():78-83. PubMed ID: 25691093
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: effect of treatment.
Pandey GN; Ren X; Rizavi HS; Dwivedi Y
J Psychiatr Res; 2010 Feb; 44(3):143-8. PubMed ID: 19717166
[TBL] [Abstract][Full Text] [Related]
3. Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder.
Li X; Friedman AB; Zhu W; Wang L; Boswell S; May RS; Davis LL; Jope RS
Biol Psychiatry; 2007 Jan; 61(2):216-22. PubMed ID: 16806104
[TBL] [Abstract][Full Text] [Related]
4. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
5. Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes.
de Sousa RT; Streck EL; Zanetti MV; Ferreira GK; Diniz BS; Brunoni AR; Busatto GF; Gattaz WF; Machado-Vieira R
Psychopharmacology (Berl); 2015 Jan; 232(1):245-50. PubMed ID: 24961563
[TBL] [Abstract][Full Text] [Related]
6. Lithium increases nitric oxide levels in subjects with bipolar disorder during depressive episodes.
de Sousa RT; Zanetti MV; Busatto GF; Mouro MG; Zarate CA; Gattaz WF; Higa EM; Machado-Vieira R
J Psychiatr Res; 2014 Aug; 55():96-100. PubMed ID: 24768108
[TBL] [Abstract][Full Text] [Related]
7. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder.
Munkholm K; Miskowiak KW; Jacoby AS; Vinberg M; Leme Talib L; Gattaz WF; Kessing LV
Eur Neuropsychopharmacol; 2018 Mar; 28(3):361-368. PubMed ID: 29433844
[TBL] [Abstract][Full Text] [Related]
9. Higher proportion of inactive Gsk3β in platelets of elderly patients with bipolar disorder: an effect of treatment?
Ladeira RB; Joaquim HP; Talib LL; Nunes PV; Forlenza OV
Braz J Psychiatry; 2013; 35(3):274-8. PubMed ID: 24142090
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3β in patients with bipolar I disorder: results from a prospective study.
Jacoby AS; Munkholm K; Vinberg M; Joaquim HG; Talib LL; Gattaz WF; Kessing LV
Bipolar Disord; 2016 Jun; 18(4):334-41. PubMed ID: 27325150
[TBL] [Abstract][Full Text] [Related]
11. Preliminary study of relationships among measures of depressive symptoms in adolescents with bipolar disorder.
Patel NC; DelBello MP; Kowatch RA; Strakowski SM
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):327-35. PubMed ID: 16768640
[TBL] [Abstract][Full Text] [Related]
12. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.
Szczepankiewicz A; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Dmitrzak-Weglarz M; Czerski PM; Hauser J
World J Biol Psychiatry; 2006; 7(3):158-61. PubMed ID: 16861141
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte mitochondrial DNA copy number in bipolar disorder.
de Sousa RT; Uno M; Zanetti MV; Shinjo SM; Busatto GF; Gattaz WF; Marie SK; Machado-Vieira R
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():32-5. PubMed ID: 24036318
[TBL] [Abstract][Full Text] [Related]
14. Why is lithium effective in alleviating bipolar disorder?
Sato K
Med Hypotheses; 2021 Feb; 147():110484. PubMed ID: 33444905
[TBL] [Abstract][Full Text] [Related]
15. Lithium-associated transcriptional regulation of CRMP1 in patient-derived olfactory neurons and symptom changes in bipolar disorder.
McLean CK; Narayan S; Lin SY; Rai N; Chung Y; Hipolito MS; Cascella NG; Nurnberger JI; Ishizuka K; Sawa AS; Nwulia EA
Transl Psychiatry; 2018 Apr; 8(1):81. PubMed ID: 29666369
[TBL] [Abstract][Full Text] [Related]
16. [Association between lithium sensitivity and GSK3beta gene polymorphisms in bipolar disorder].
Numajiri M; Aoki J; Iwahashi K; Fukamauchi F; Enomoto M; Yoshihara E; Murayama O; Nishizawa D; Ikeda K; Ishigooka J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Jun; 32(3):161-3. PubMed ID: 22834106
[TBL] [Abstract][Full Text] [Related]
17. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte telomerase activity and antidepressant efficacy in bipolar disorder.
Soeiro-de-Souza MG; Teixeira AL; Mateo EC; Zanetti MV; Rodrigues FG; de Paula VJ; Bezerra JF; Moreno RA; Gattaz WF; Machado-Vieira R
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1139-43. PubMed ID: 24731723
[TBL] [Abstract][Full Text] [Related]
19. GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression.
Pláteník J; Fišar Z; Buchal R; Jirák R; Kitzlerová E; Zvěřová M; Raboch J
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():83-93. PubMed ID: 24334212
[TBL] [Abstract][Full Text] [Related]
20. Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study.
Machado-Vieira R; Zanetti MV; Otaduy MC; De Sousa RT; Soeiro-de-Souza MG; Costa AC; Carvalho AF; Leite CC; Busatto GF; Zarate CA; Gattaz WF
J Clin Psychopharmacol; 2017 Feb; 37(1):40-45. PubMed ID: 27902528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
